Moderna 2022 Priorities and Capital Allocation

Financial highlights First quarter 2022 GAAP financial results • Revenue: $6.1B • Net income: $3.7B • Diluted EPS: $8.58 • Cash and investments: $19.3B (as of 03/31/22) Reduced outstanding shares again in 1 Q22 2022 outlook Reiterating~$21B in signed advanced purchase agreements Slide 4 moderna

View entire presentation